Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

Delayed Data
As of 2:33pm ET
 +0.0168 / +2.57%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 13.50, with a high estimate of 19.00 and a low estimate of 8.00. The median estimate represents a +1,911.62% increase from the last price of 0.67.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.30%
Growthannually 13.82%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.